• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 01/28/15

    • 30-Day SEC Yield1

      1.78%
    • Total Net Assets

      $352.2M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2015
  • Portfolio Composition (%)
    as of 01/28/15

    • % of Net Assets
    • Stocks

      100.25
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.25
  • Download All HoldingsAll Holdings (%) as of 01/28/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    335,693
    32,599,1489.26
    Johnson & Johnson
    JNJ US
    303,359
    30,784,8728.74
    Pfizer Inc
    PFE US
    723,983
    23,131,2566.57
    Glaxosmithkline Plc
    GSK US
    399,773
    17,985,7885.11
    Merck & Co Inc
    MRK US
    289,865
    17,812,2045.06
    Sanofi
    SNY US
    379,113
    17,458,1544.96
    Novo Nordisk A/S
    NVO US
    379,775
    17,082,2804.85
    Allergan Inc/United States
    AGN US
    74,477
    16,560,7064.70
    Actavis Plc
    ACT US
    60,460
    16,558,7854.70
    Bristol-Myers Squibb Co
    BMY US
    263,959
    16,188,6054.60
    Abbvie Inc
    ABBV US
    257,268
    15,912,0264.52
    Eli Lilly & Co
    LLY US
    220,233
    15,629,9364.44
    Valeant Pharmaceuticals International I
    VRX US
    95,803
    15,385,0044.37
    Abbott Laboratories
    ABT US
    352,660
    15,308,9714.35
    Astrazeneca Plc
    AZN US
    212,517
    15,090,8324.29
    Teva Pharmaceutical Industries Ltd
    TEVA US
    245,558
    14,225,1754.04
    Shire Plc
    SHPG US
    62,534
    13,723,0863.90
    Mckesson Corp
    MCK US
    61,841
    13,477,6283.83
    Mylan Inc/Pa
    MYL US
    108,772
    6,008,5661.71
    Zoetis Inc
    ZTS US
    138,840
    5,985,3931.70
    Perrigo Co
    PRGO US
    38,987
    5,984,8951.70
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    36,264
    2,944,4560.84
    Mallinckrodt Plc
    MNK US
    26,637
    2,819,5270.80
    Hospira Inc
    HSP US
    42,810
    2,767,6670.79
    Salix Pharmaceuticals Ltd
    SLXP US
    12,854
    1,643,8980.47
    Other/Cash
    -895,055-0.25
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.